Inventor · disambiguated record
Lewis L. Lanier
Also filed as: LANIER LEWIS · LANIER LEWIS L
20 granted patents·22 pending applications·247 citations·filing 1983–2023
95Inventor score
Top patents by PatentIndex Score
42 records- 0191US6953843B2Antibodies and fragments thereof to MDL-1 proteinSCHERING CORP·Filed 2002·Granted Oct 11, 2005·17 cites·4 claims
- 0289US7332574B2MDL-1 polypeptidesSCHERING CORP·Filed 2004·Granted Feb 19, 2008·12 cites·22 claims
- 0389US6479638B1Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptorSCHERING CORP·Filed 2000·Granted Nov 12, 2002·19 cites·5 claims
- 0485US7319140B2Binding compounds to DAP12 proteinsSCHERING CORP·Filed 2004·Granted Jan 15, 2008·13 cites·18 claims
- 0585US6416973B1Nucleic acids encoding mammalian cell membrane protein MDL-1SCHERING CORP·Filed 1998·Granted Jul 9, 2002·29 cites·9 claims
- 0683US7999078B2Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptorSCHERING CORP·Filed 2008·Granted Aug 16, 2011·2 cites·24 claims
- 0783US7659093B2DAP12 nucleic acidsSCHERING CORP·Filed 2007·Granted Feb 9, 2010·3 cites·8 claims
- 0874US9211328B2Modulation of NKG2D for prolonging survival of a hematopoietic graftUNIV CALIFORNIA·Filed 2013·Granted Dec 15, 2015·2 cites·17 claims
- 0973US6140076AIg superfamily `dlair` receptors expressed in monocytesSCHERING CORP·Filed 1997·Granted Oct 31, 2000·21 cites·61 claims
- 1071US2024041994A1Cmv vaccine and method of making and using the sameUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1169US2009263403A1Mammalian cell membrane proteins; related reagentsSCHERING CORP·Filed 2009·Application pending·0 cites
- 1268US8637011B2Modulation of NKG2DBARON JODY L·Filed 2007·Granted Jan 28, 2014·1 cites·23 claims
- 1368US4607007ADifferentiation of natural killer cell subpopulations of cellsBECTON DICKINSON CO·Filed 1983·Granted Aug 19, 1986·25 cites·12 claims
- 1467US2014141444A1Isolated Mammalian Monocyte Cell Genes; Related ReagentsADEMA GOSSE JAN·Filed 2014·Application pending·0 cites
- 1567US2005059808A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1667US2014141445A1Isolated Mammalian Monocyte Cell Genes; Related ReagentsADEMA GOSSE JAN·Filed 2014·Application pending·0 cites
- 1767US2004143858A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1866US4599304AMethod for monitoring activated cell subpopulationsBECTON DICKINSON CO·Filed 1983·Granted Jul 8, 1986·23 cites·7 claims
- 1965US5041289AMethod of purging residual tumor cells in vitro with lymphokine activated cytotoxic cellsBECTON DICKINSON CO·Filed 1987·Granted Aug 20, 1991·11 cites·13 claims
- 2065US2008171035A1Mammalian cell membrane proteins; related reagentsSCHERING CORP·Filed 2008·Application pending·0 cites
- 2164US2025152716A1Improved primary human nk cell expansion and function by chimeric cytokine receptorUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2264US2013034561A1Isolated mammalian monocyte cell genes; related reagentsMERCK SHARP & DOHME·Filed 2012·Application pending·0 cites
- 2364US2003105303A1Isolated mammalian monocyte cell genes; related reagentsSCHERING CORP·Filed 2002·Application pending·0 cites
- 2462US2005287582A1Antibodies that specifically bind to FDF03SCHERING CORP·Filed 2005·Application pending·0 cites
- 2561US5770387AAntibodies to mammalian NK antigens and usesSCHERING CORP·Filed 1996·Granted Jun 23, 1998·14 cites·28 claims
- 2661US5124251ACD3 ζ co-associated complex on CD16- NK cellsBECTON DICKINSON CO·Filed 1990·Granted Jun 23, 1992·17 cites·7 claims
- 2761US2012020990A1Isolated mammalian monocyte cell genes; related reagentsADEMA GOSSE JAN·Filed 2011·Application pending·0 cites
- 2860US5965401APurified mammalian NK antigens and related reagentsSCHERING CORP·Filed 1996·Granted Oct 12, 1999·11 cites·28 claims
- 2960US2009012270A1Ox2 receptor homologsBARCLAY A NEIL·Filed 2008·Application pending·0 cites
- 3058US2024327523A1Depleting monoclonal antibodies against natural killer cellsUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3158US2010129374A1Mammalian Cell Membrane Proteins; Related ReagentsSCHERING CORP·Filed 2010·Application pending·0 cites
- 3257US2020171135A1CMV Vaccine and Method of Making and Using the SameUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 3356US7998481B2Modulation of NKG2D for treating or preventing solid organ allograft rejectionUNIV CALIFORNIA·Filed 2006·Granted Aug 16, 2011·0 cites·26 claims
- 3455US2024279331A1Antibodies that stimulate nk cell-mediated cytotoxicityUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3554US5811284ANucleic acids encoding kp43 protein and antigenic fragments thereofSCHERING CORP·Filed 1996·Granted Sep 22, 1998·19 cites·15 claims
- 3653US2006084121A1OX2 receptor homologsBARCLAY A N·Filed 2005·Application pending·0 cites
- 3751US2012231003A1Ox2 Receptor HomologsBARCLAY A NEIL·Filed 2012·Application pending·0 cites
- 3850US2012064070A1Modulation of nkg2dLANIER LEWIS L·Filed 2011·Application pending·0 cites
- 3949US4895796AIdentification of NK cells and cytotoxic T lymphocytesBECTON DICKINSON CO·Filed 1988·Granted Jan 23, 1990·8 cites·17 claims
- 4046US2008260727A1Modulation of Nkg2dUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 4141US2016311906A1Modulation of nkg2dUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 4231US9683996B2Assessment of solid tumor burdenPARSA ANDREW T·Filed 2010·Granted Jun 20, 2017·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →